The protective effects of naringin against 5-fluorouracil-ınduced hepatotoxicity and nephrotoxicity in rats

Document Type : Original Article

Authors

1 Department of Physiology, Veterinary Faculty, Kafkas University, Kars, Turkey

2 Department of Physiology, Veterinary Faculty, Ataturk University, Erzurum, Turkey

3 Department of Pathology, Veterinary Faculty, Ataturk University, Erzurum, Turkey

Abstract

Objective(s): 5-FU, an anticarcinogenic agent, is reported to have side-effects that include hepatotoxicity and nephrotoxicity. The study objective was to investigate the protective effects of naringin on 5-FU-induced hepatotoxicity and nephrotoxicity.
Materials and Methods: Thirty rodents were assigned to three groups. The control group received 1 ml of intragastric distilled water for 14 days. The 5-FU group received 1 ml of distilled water for 14 days as a placebo. On day 9, this same group received a 20 mg/kg dose of 5-FU administered intraperitoneally(IP) for a further five days. The naringin+5-FU group received a 100 mg/kg dose of naringin (IP) for 14 days. On day 9, 20 mg/kg of 5-FU was administered (IP) to this group for a further five days. On day 15, the rats were decapitated, and blood and renal and hepatic tissues were taken.
Results: It was determined that serum creatinine, BUN, AST, ALT, ALP, and LDH levels, as well as cytokine levels in the liver and kidney tissues were significantly elevated in the 5-FU group, compared to the control group. The comparative values were similar in the control and naringin+5-FU groups. When the liver tissue was examined histopathologically, in the control group it was found to be normal in structure. However, necrosis was observed in the hepatocytes of the pericentric region in the 5-FU group. 8-OHdG cell density was significantly elevated in the 5-FU group, compared to the control and naringin+5-FU groups.
Conclusion: Naringin was observed to have a protective effect on 5-FU-induced liver and kidney damage.

Keywords

Main Subjects


1. Longley DB,  Harkin DP,  Johnston PG. 5- Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003;3:330-338.
2. Cabellos R, Garcia-Carbonero R, Garcia-Lacalle C, Gomez P, Tercero A, Sanchez D, et al. Fluorouracil-based chemotherapy in patients with gastrointestinal malignancies: influence of nutritional folate status on toxicity. J Chemother 2007;19:744-749.
3. Isaka Y, Rakugi H.  Severe adverse effects of 5-fluorouracil in S-1 were lessened by haemodialysis due to elimination of the drug, NDT. Plus Advance Access 2009;18:152-154.
4. Gelen V,  Şengül E, Gedikli S, Atila G, Uslu H, Makav M. The protective effect of rutin and quercetin on 5-FU-induced hepatotoxicity in rats. Asian Pac J Trop Biomed 2017;7:647-653.
5. Ray S, Roy K, Sengupta C. In vitro evaluation of protective effects of ascorbic acid and water extract of Spirulina plantesis (blue green algae) on 5-fluorouracil-induced lipid peroxidation. Acta Pol Pharm 2007;64: 35-44.
6. Şengül E, Gelen V, Gedikli S, Özkanlar S, Gür S, Çelebi F, et al. The protective effect of quercetin on cyclophosphamide-Induced lung toxicity in rats. Biomed Pharmacother 2017;92:303-307.
7. Choi JAS, Piao YJ, Kang KW. Effect of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and Pgp inhibition by quercetin. Arch Pharm Res 2011;34:607-620.
8. Swamy AH, Patel UM, Koti BC, Gadad PC, Patel NL, Thippeswamy AH. Cardioprotective effect of Saracaindicavagainst cyclophosphamide induced cardio toxicity in rats: a biochemical, electrocardiographic and histopathological study. Indian J Pharmacol 2013;45:48-56.
9. Raskovic A, Stilinovic N, Kolarovic J, Vasovic V, Vukmirovic S, Mikov M. The Protective Effects of Silymarin against Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity in Rat. Molecules 2011;16: 8601-8614.
10. Matouk AI, Taye A, Heeba GH, El-Moselhy MA.  Quercetin augments the protective effect of losartan against chronic doxorubicin cardiotoxicity in rats. Environ Toxicol Pharmacol 2013;36: 443-493.
11. Igual M, Garcia-Martinez E, Camacho MM, Martinez-Navarrete N. Jam processing and storage effects on β-carotene and flavonoids content in grapefruit. J Funct Foods 2013;5:736–744.
12. Oršolić N, Gajski G, Garaj-Vrhovac V, Đikić D,  Prskalo ZS,  Sirovina D. DNA-protective effects of quercetin or naringin in alloxan-induced diabetic mice. Eur J Pharmacol 2011;10:110-118.
13. Leopoldini M, Russo N, Toscano M.The molecular basis of working mechanism of natural polyphenolic antioxidants. Food Chem 2011;125:288-306.
14. Lee MH, Yoon S, Moon JO. The flavonoid naringin inhibits dimethylnitrosamine-induced liver damage in rats. Biol Pharm Bull 2004;27: 72-76.
15. Singh D, Chander V, Chopra K. Protective effect of naringin, a bioflavonoid on ferric nitrilotriacetate-induced oxidative renal damage in rat kidney. Toxicology 2004; 201:1-8.
16. Shi Z, Cao J, Chen J, Li S, Zhang Z, Yang B, et al. Butenolide induced cytotoxicity by disturbing the prooxidant–antioxidant balance, and antioxidants partly quench in human chondrocytes. Toxico in Vitro 2009;23:99-104.
17. Skretkowicz J, Sekulska M, Danilewicz M, Wagrowska-Danilewicz M, Polakowski P. Effect of some anticancer drugs and combined chemotherapy on renal toxicity. Biol Signals 1996;5:51-58.
18. El-Sayyad HI, Ismail MF, Shalaby FM, Abou-El- Magd RF, Gaur RL, et al. Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats. Int J Sci 2009;5:466-473.
19. Gulcin I, Berashvili D, Gepdiremen A. Antiradical and antioxidant activity of total anthocyanins from Perilla pankinensis decne. J Ethnopharmacol 2005;101:287–293.
20. Polidoro G, Dillio C, La Rovere G, Fedrici GS. Superoxide dismutase, reduced glutathione and TBA-reactive products in erythrocytes of patients with multiple sclerosis. Int J Biochem 1984;16:505–509.
21. Polat Köse L, Gülçin I, Gören AC, Namiesnik J, Martinez-Ayala AL, Gorinstein S.  LC-MS/MS analysis, antioxidant and anticholinergic properties of galanga (Alpinia officinarum Hance) rhizomes. Ind Crops Prod 2015;74:712–721.
22. Gulcin I, Beydemir S. Phenolic compounds as antioxidants: Carbonic anhydrase isoenzymes inhibitors. Mini Rev Med Chem 2013;13:408–430.
23. Sehitoglu MH, Han H,  Kalin P, Gulcin I, Ozkan A, Aboul-Enein HY, et al. Gum A potent inhibitor of reactive oxygen specie. J Enzym Inhib Med Chem 2015;30:264–269.
24. Bae JH,  Park YJ, Namiesnik J, Gülçin I,  Kim TC, Kim HC,  et al.  Effects of artificial lighting on bioactivity of sweet red pepper (Capsicum annuum L.). Int J Food Sci Technol 2016;51:1378–1385.
25. Yao X, Panichpisal K,  Kurtzman N, Nugent K. Cisplatin nephrotoxicity, A review. Am J Med Sci 2007;334:115–124.
26. Ren W, Wang X, Zhang A, Li C, Chen G, Ge X, et al. Selective bowel decontamination improves the survival of 90% hepatectomy in rats. J Surg Res 2015;195:454–464.
27. Alwahsh SM, Xu M, Seyhan SA, Ahmad S, Mihm S, Ramadori G, et al.  Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty live. World J Gastroenterol 2014;20:1807–1821.
28. Godos J, Federico A, Dallio M, Scazzina F. Mediterranean diet and nonalcoholic fatty liver disease: Molecular mechanisms of protection. Int J Food Sci Nutr 2017;68:18–27.
29. Gulcin I. Antioxidant and antiradical activities of L-Carnitine. Life Sci 2006;78:803–811.
30. Buyukokuroglu ME, Gulcin I, Oktay M, Kufrevioglu O. In vitro antioxidant properties of dantrolene sodium. Pharmacol Res 2001;44:491–494.
31. Gulcin I, Buyukokuroglu ME, Oktay M, Kufrevioglu OI. In vitro antioxidant properties of dantrolene sodium. Antioxidant and analgesic activities of turpentine of Pinus nigra Arn. Subsp. pallsiana (Lamb.) Holmboe. J Ethnopharmacol 2003;86:51–58.
32. Nora El-Hoseany MA.  Protective Effect of Captopril against 5-Fluorouracil-Induced Hepato and Nephrotoxicity in Male Albino Rats. J American Sci 2012;8:680-685.
33. Afolabi OK,  Adeleke1 GE, Ugbaja RN. Crocin Alleviates 5-Fluorouracil-induced Hepatotoxicity through the abrogation of Oxidative Stress in Male Wistar rats. Asian Pac J Health Sci 2016;3:58-68.
34. Dimitriu D, Lupusoru C, Cojocaru I, Gafitanu C, Palade L, Lupusoru R. Assessing biochemical andoxidative stress parameters after vaginal and oral administration of 5-fluorouracil in laboratory animals. Farmacia 2015; 63:230-233.
35. Stockham SL, Scott MA. Fundamentals of Veterinary Clinical Pathology, Ames, Iowa State University Press 2002;52:434–459.
36. Zeashan H, Amresh G, Singh S, Rao CV. Hepatoprotective and antioxidant activity of Amaranthus spinosus against CCl4 induced toxicity. J Ethnopharmacol 2009;125:364–366.
37.  MacNamara E,  Goldberg DM. Serum enzymes and enzyme profiles in the diagnosis of liver and biliary tract diseas. Surv Dig Dis 1985;3:165–186.
38. Nada O.  A review of propolis antitumour action in vivo and in vitro. J Api Product Api Med Sci 2010;2:1–20.
39. Laverty HG, Antoine DJ, Benson C, Chaponda M, Williams D, Park BK. The potential of cytokines as safety biomarkers for drug-induced liver injury.  Eur J Clin Pharmacol 2010;66:961–976.
40. Lacour S, Gautier JC, Pallardy M, Roberts R. Cytokines as potential biomarkers of liver toxicity. Cancer Biomarkers 2005;1:29–39.
41. Chang CT,  Ho TY, Lin H, Liang JA, Huang HC. 5-Fluorouracil induced intestinal mucositis via nuclear factor-kB activation by transcriptomic analysis and in vivo bioluminescence imaging. PLoS ONE 2017;7: e31808.
42. Peluso I, Raguzzini A, Serafini M. Effect of flavonoids on circulating levels of TNF-α and IL-6 in humans: a systematic review and meta-analysis. Mol Nutr Food 2015;57:784-801.
43. Pinho-Ribeiro FA, Zarpelon AC,  Mizokami SS, Borghi SM, Bordignon J, Silva RL, et al. The citrus flavonone naringin reduces lipopolysaccharide-induced inflammatory pain and leukocyte recruitment by inhibiting NF-κB activation. J Nutr Biochem 2016;33:8-14.
44. Hak, Heba Nageh Gad EL, Tarek Ibrahim Saad M, Gamal Abdel-A. “Histological study of the effect of chemotherapy with 5-Fluorouracil on normal liver and kidney of mice. International J Novel Res Life Sci 2015;2:8-13.
45. Cadet J, Douki T, Gasparutto D, Ravanat JL. Oxidative damage to DNA: formation, measurement and biochemical features. Mutat Res Fund Mol M 2003; 531:5–23.
46. Stepniak J, Karbownik-Lewinska M. 17 β-estradiol prevents experimentally-induced oxidative damage to membrane lipids and nuclear DNA in porcine ovary. Sys Biol Reprod Med 2016;62:17–21.
47. Cadet J. Oxidative degradation pathways of cellular DNA: product formation and mechanistic insights. Free Radical Biol Med 2016;75:S2.
48. El-Sayyad IH,  Hassan A. Effects of adriamycin, cisplatin, and 5-fluorouracil on the testes of albino rats. Br J Med Health Sci 2013;1:45-62.
49. Ince S, Arslan Acaroz D, Neuwirth O, Hasan Hüseyin D, Barıs D, İsmail K, et al. Protective effect of polydatin, a natural precursor of resveratrol, against cisplatininduced toxicity in rats. Food Chem Toxicol 2014;72:147-153.